Eculizumab Use for Kidney Transplantation in Patients With a Diagnosis of Atypical Hemolytic Uremic Syndrome

INTRODUCTION: Recurrence of atypical hemolytic uremic syndrome (aHUS) in renal allografts is common, leading to dialysis and graft failure. Pretransplant versus posttransplant initiation of eculizumab treatment in patients with aHUS has not been rigorously investigated. We hypothesized eculizumab pr...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Kidney Int Rep
Hlavní autoři: Siedlecki, Andrew M., Isbel, Nicole, Vande Walle, Johan, James Eggleston, Jennifer, Cohen, David J.
Médium: Artigo
Jazyk:Inglês
Vydáno: Elsevier 2018
Témata:
Clinical Research
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6409407/
https://ncbi.nlm.nih.gov/pubmed/30899871
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ekir.2018.11.010
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky